We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YUMC:NYSEYum China Holdings, Inc. Analysis

Data as of 2026-05-12 - not real-time

$47.44

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Yum China delivered a solid top‑line beat with 9.7% revenue growth and 12% operating profit growth in Q1, driven by record new store openings. Adjusted EPS of $0.87 surpassed consensus estimates, and the company continues to return cash with a 2.45% dividend yield and a modest 38% payout ratio. Technically, the stock trades at $47.44, just above the identified support of $46.84, while the 20‑day SMA (48.34) sits below the 50‑day SMA (50.11), indicating a neutral to slightly bearish price trend. However, the RSI of 41 and a bullish MACD histogram (+0.02) suggest limited downside pressure, and volume is on an increasing trend, providing liquidity for the next move.
Valuation metrics show the DCF‑derived fair value of $42.80 is below the current price, implying the stock is slightly overvalued despite a forward PE of 14.55 that hints at upside potential. The beta of 0.56 (or 0.12 per market data) points to low market sensitivity, while 30‑day volatility sits near 23%, reflecting a moderately volatile environment. Dividend sustainability appears strong given positive free cash flow and a comfortable coverage ratio. Investors should weigh the growth narrative against the modest valuation premium and the inherent regulatory and geographic risks of operating primarily in China.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Earnings beat and strong same‑store sales
  • Price near technical support with low beta
  • Increasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust revenue and operating profit growth
  • Forward PE compression to 14.5x
  • Sustainable dividend yield

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Dominant market position in China’s quick‑service segment
  • Dividend sustainability and cash flow generation
  • Potential regulatory and macro‑economic headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth9.70%
Profit Margin7.83%
P/E Ratio18.9
ROE16.29%
ROA7.84%
Debt/Equity38.01
P/B Ratio3.1
Op. Cash Flow$1.6B
Free Cash Flow$788.4M

Technical Analysis

TrendNeutral
RSI41.6
Support$46.84
Resistance$50.40
MA 20$48.34
MA 50$50.11
MA 200$47.78
MACDBullish
VolumeIncreasing
Fear & Greed Index88.61

Valuation

Fair Value$42.80
Target Price$61.69
Upside/Downside30.04%
GradeOvervalued
TypeBlend
Dividend Yield2.45%

Risk Assessment

Beta0.56
Volatility23.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.